Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient preferences and health state utilities associated with dulaglutide and semaglutide injection devices among patients with type 2 diabetes in Italy.
Boye KS, Matza LS, Stewart KD, Jordan J, Biricolti G, Del Santo S, Perez-Nieves M, Federici MO, Gentilella R, Losi S, Norrbacka K. Boye KS, et al. Among authors: norrbacka k. J Med Econ. 2019 Aug;22(8):806-813. doi: 10.1080/13696998.2019.1609482. Epub 2019 May 17. J Med Econ. 2019. PMID: 31010349 Free article.
Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes.
Matza LS, Boye KS, Jordan JB, Norrbacka K, Gentilella R, Tiebout AR, Browne C, Orsini Federici M, Biricolti G, Stewart KD. Matza LS, et al. Among authors: norrbacka k. Patient Prefer Adherence. 2018 Jun 6;12:971-979. doi: 10.2147/PPA.S159620. eCollection 2018. Patient Prefer Adherence. 2018. PMID: 29922043 Free PMC article.
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes.
Boye KS, Sapin H, García-Pérez LE, Rosilio M, Orsini Federici M, Heitmann E, Jung H, Aigner U, Guerci B, Giorgino F, Norrbacka K. Boye KS, et al. Among authors: norrbacka k. Diabetes Ther. 2020 Oct;11(10):2383-2399. doi: 10.1007/s13300-020-00908-9. Epub 2020 Sep 3. Diabetes Ther. 2020. PMID: 32880876 Free PMC article.
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics.
García-Pérez LE, Boye KS, Rosilio M, Jung H, Heitmann E, Norrbacka K, Federici MO, Gentilella R, Guerci B, Giorgino F, Aigner U, Sapin H. García-Pérez LE, et al. Among authors: norrbacka k. Diabetes Ther. 2021 Jul;12(7):1929-1946. doi: 10.1007/s13300-021-01076-0. Epub 2021 Jun 7. Diabetes Ther. 2021. PMID: 34097244 Free PMC article.
27 results